Emergent BioSolutions, Inc. (EBS)
6.09
-0.01
(-0.16%)
USD |
NYSE |
Nov 10, 09:42
Emergent BioSolutions Cash and Short Term Investments (Quarterly) : 176.90M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 176.90M |
| June 30, 2026 | 140.90M |
| March 31, 2026 | 161.50M |
| December 31, 2025 | 209.10M |
| September 30, 2025 | 249.20M |
| June 30, 2025 | 271.00M |
| March 31, 2025 | 152.80M |
| December 31, 2024 | 105.60M |
| September 30, 2024 | 156.40M |
| June 30, 2024 | 71.00M |
| March 31, 2024 | 79.00M |
| December 31, 2023 | 111.70M |
| September 30, 2023 | 87.80M |
| June 30, 2023 | 88.60M |
| March 31, 2023 | 430.20M |
| December 31, 2022 | 642.60M |
| September 30, 2022 | 241.00M |
| June 30, 2022 | 358.30M |
| March 31, 2022 | 436.00M |
| December 31, 2021 | 576.30M |
| September 30, 2021 | 404.00M |
| June 30, 2021 | 447.70M |
| March 31, 2021 | 548.00M |
| December 31, 2020 | 621.50M |
| September 30, 2020 | 415.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 269.00M |
| March 31, 2020 | 181.70M |
| December 31, 2019 | 168.00M |
| September 30, 2019 | 139.40M |
| June 30, 2019 | 177.60M |
| March 31, 2019 | 137.40M |
| December 31, 2018 | 112.40M |
| September 30, 2018 | 340.40M |
| June 30, 2018 | 191.28M |
| March 31, 2018 | 164.65M |
| December 31, 2017 | 179.34M |
| September 30, 2017 | 342.03M |
| June 30, 2017 | 315.63M |
| March 31, 2017 | 270.17M |
| December 31, 2016 | 271.51M |
| September 30, 2016 | 298.93M |
| June 30, 2016 | 333.40M |
| March 31, 2016 | 341.02M |
| December 31, 2015 | 308.30M |
| September 30, 2015 | 308.72M |
| June 30, 2015 | 214.84M |
| March 31, 2015 | 216.52M |
| December 31, 2014 | 280.50M |
| September 30, 2014 | 242.25M |
| June 30, 2014 | 168.13M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.313B |
| Arcturus Therapeutics Holdings, Inc. | 184.82M |
| Capricor Therapeutics, Inc. | 237.93M |
| Travere Therapeutics, Inc. | 471.82M |
| Syndax Pharmaceuticals, Inc. | 427.10M |